On October 18, 2022, the Company licensed from Therapeutic Solutions International, Inc., the following patent:

U.S. Patent No.: 9,803,176 titled as: Methods And Compositions For The Clinical Derivation Of An Allogenic Cell And Therapeutic Uses.